603233 DaShenLin Pharmaceutical Group
- 14.22
- -0.01-0.07%
DaShenLin Pharmaceutical Group News
Research Reports Gold Digging | Wanlian Securities: Initiates a "Buy" rating for DaShenLin Pharmaceutical Group, a leading large chain pharmacy enterprise in the country.
Daisanlin (603233): Deep-rooted in South China expands the country's leading pharmacy chain
Daisenbayashi (603233): Steady revenue growth and expectations for improved profitability
Dashenlin (603233): Revenue is growing rapidly, and cost control is beginning to bear fruit
Daisenlin (603233): Performance is in line with expectations and deepens national layout
Daisenlin (603233): Steady growth in performance, rapid expansion of franchise stores
Dashenlin (603233): The national layout has basically been completed, and the stage of deepening market cultivation has begun
Dashanlin (603233): Stores maintain high growth and upward inventory turnover
Daisenlin (603233): The growth rate of the franchise business is impressive, and the nationwide layout of stores continues to advance
Daisenbayashi (603233): Short-term performance is under pressure to strengthen the national layout
Dashenlin (603233): Revenue growth is slowing down, gross margin is being phased under pressure
Daishanlin (603233): 2024H1 profit temporarily declined due to declining spending power and more new stores in the cultivation period
Dashenlin (603233): Deeply involved in South China and the continuous development of the country's leading chain of high-quality pharmacies
Daisenlin (603233): Continued expansion of stores and accelerated development of franchise business
Dashanlin (603233): 2024Q1 performance is under short-term pressure, and the nationwide layout of stores is still progressing
Dashanlin (603233): Direct franchise advantages highlight the continuous increase in the number of stores
Dashanlin (603233): Diversified store expansion towards national performance is disrupted by the short-term pace of store construction
Daisenbayashi (603233): Performance is in line with expectations, self-construction accelerates quarter by quarter
Dashanlin (603233): Store expansion accelerates upward inventory turnover
Daishanlin (603233): Continued store expansion and short-term pressure on performance under high base
No Data